SNPMiner Trials by Shray Alag


SNPMiner Trials: Clinical Trial Report


Report for Clinical Trial NCT03203486

Developed by Shray Alag, 2019.
SNP Clinical Trial Gene

The Effectiveness of a Mediterranean Diet Intervention in NAFLD Clinical Course

The effects of Mediterranean Diet (MedDiet) on clinical, biochemical and inflammatory profile in NAFLD patients with simple steatosis. Potential associations of single nucleotide polymorphisms to diet composition and patients' profile were also investigated.

NCT03203486 NAFLD Steatosis of Liver
MeSH: Non-alcoholic Fatty Liver Disease Fatty Liver
HPO: Hepatic steatosis

1 Interventions

Name: Mediterranean Diet

Description: Participants were instructed to include vegetables, whole grains and fruits in their diet and increase fish, legumes and raw nut intake. Emphasis was given to extra virgin olive oil as the main added fat in meals. Particular attention was drained to decrease fermented dairy and poultry, with small amounts of red meat and homemade sweets. All participants were given meal plans in which the distribution of nutrients in relation to total caloric value was as follows: 40% of total energy as fat (50% as MUFAs), 20% as protein, 40% as carbohydrate, 300mg/d as dietary cholesterol and 20-30g fiber/d.

Type: Other

Meditteranean Diet


Primary Outcomes

Description: A decrease in liver fat

Measure: Regulation of hepatic steatosis

Time: Change from Baseline to 6 months

Secondary Outcomes

Description: Increase in MedDietScore

Measure: Adherence to MedDiet

Time: Change from Baseline to 6 months

Description: Decrease in visfatin levels

Measure: Regulation of visfatin

Time: Change from Baseline to 6 months

Description: Decrease in oxLDL levels

Measure: Regulation of oxLDL

Time: Change from Baseline to 6 months

Description: Decrease in visfatin in carriers of the risk allele

Measure: Association of single nucleotide polymorphisms to response to dietary treatment

Time: Change from Baseline to 6 months

Purpose: Other

Single Group Assignment


There are 2 SNPs

SNPs


1 rs1260326

Furthermore, genotyping of STAT3 rs2293152 and GCKR rs1260326 single nucleotide polymorphisms takes place.


2 rs2293152

Furthermore, genotyping of STAT3 rs2293152 and GCKR rs1260326 single nucleotide polymorphisms takes place.



HPO Nodes


HPO:
Hepatic steatosis
Genes 102
GABRD GPD1 HFE MPV17 LDLRAP1 TRAPPC11 HNF1B PNPLA2 ATP6AP1 ATP7B ZMPSTE24 ACADL ACADM ACADVL EARS2 LYRM4 DNAJC19 CYP7A1 MARS IARS ACAD9 POLD1 FOS ACOX1 RRM2B CYP19A1 POLG MRPL44 VPS33A AGPAT2 ETFA ETFB TMEM199 ETFDH LARS KCNAB2 FARSB COX15 APOB LMNB2 CAV1 MCCC1 APOE PPARG CPT1A XRCC4 TARS2 CPT2 SKI NSMCE2 TYMP HNF4A BCS1L HNRNPA1 CBS TFAM HNRNPA2B1 LDLR SLC40A1 COA8 DDOST PGM1 POLR3A ADK TRMU MRPS7 LRPPRC LIPA LIPE ABHD5 FBP1 NDUFAF1 LMNA ALMS1 CLPB COG6 DGUOK CIDEC SLC25A13 SAR1B SLC22A5 AKT2 CAVIN1 BSCL2 HADHA HADHB RERE HADH RMND1 HSD17B4 PLIN1 CARS2 ALDOB PRDM16 ABCG5 PCK1 ABCG8 PCK2 VCP PCSK9 CEP19 PMM2